Imago Biosciences Inc (IMGO) Financials

$36.01

$0.00 (0.00%)

As on 13-Jan-2023 09:30EDT

Market cap

$1,219 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	62.89	42.52	18.07	10.66	--	--
Operating Profit (EBIT)	-62.89	-42.52	-18.07	-10.66	--	--
Other Income	0.76	-0.10	--	--	--	--
Profit before Tax	-61.64	-42.31	-17.83	-10.90	--	--
Provision for Tax	0.00	0.00	0.00	--	--	--
Profit after Tax (Net Income)	-61.64	-42.31	-17.83	-10.90	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-61.64	-42.31	-17.83	-10.90	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	172.62	214.69	-68.78	-51.40	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	162.61	57.27	--	--
Current Liabilities	13.84	10.09	5.11	2.64	--	--
Total Liabilities	200.30	224.79	98.93	8.50	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	4.42	3.48	21.11	0.01	--	--
Current Assets	182.04	221.30	77.82	8.49	--	--
Total Assets	200.30	224.79	98.93	8.50	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	168.20	211.21	72.72	5.85	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-39.76	-16.94	-10.01	--	--
Cash Flow from Investing Activities	--	-129.27	-74.34	-2.73	--	--
Cash from Financing Activities	--	160.99	105.59	16.44	--	--
Net Cash Inflow / Outflow	--	-8.04	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-2.30	-2.64	-17.83	--	--	--
Cash EPS ($)	--	-2.64	-17.83	--	--	--
Adjusted Book Value ($)	--	13.42	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.49	-16.94	--	--	--
Free Cash Flow per Share ($)	--	-2.49	-16.95	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-58.00	29.68	--	--	--
ROE (%)	-33.13	-58.00	29.68	--	--	--
ROA (%)	-27.61	-26.14	-33.20	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-8,110.13	42,738.38	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-124.36	-136.17	-66.87	--	--	--
Net Profit Growth (%)	-86.02	-137.26	-63.58	--	--	--
EPS Growth (%)	89.50	0.85	--	--	--	--
Book Value Growth (%)	-39.97	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-8.97	--	--	--	--
Price / Book Value	7.04	1.77	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-16.49	-3.86	--	--	--	--
Close Price ($)	15.05	23.71	--	--	--	--
High Price ($)	30.21	35.68	--	--	--	--
Low Price ($)	11.56	14.61	--	--	--	--
Market Cap ($ Cr)	1,218.62	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	13.16	21.93	15.24	3.22	--	--
Quick Ratio	13.16	--	--	--	--	--
Interest Coverage	-127.67	-133.74	-370.46	-280.42	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.